The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
📩 Subscribe
// STATE LEGISLATION TRACKER

Montana HB 783 — Generally revise health insurance laws relating to certain conditions

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown
State
Montana
Bill
HB 783
Filed
2024-12-14
Read the bill
OpenStates →
Last reviewed
2026-06-21

Plain-English Summary

Montana HB783 appears to revise health insurance laws for certain conditions. Based only on the title and the unavailable/latest-action data, it does not show a direct peptide-ecosystem impact.

Key Points

  • No clear peptide, compounding, or prescribing language is available
  • No clear effect on off-label peptide prescribing is shown
  • No clear change to telehealth, NP, or naturopathic scope is shown
  • No clear FDA 503A/503B or controlled-substance impact is shown

What to Watch For

i
Note Check the full bill text for any insurance coverage rules tied to hormone, metabolic, or chronic-condition care.
i
Note Watch for amendments that mention compounded drugs, prior authorization, or provider scope.
i
Note Status could not be confirmed from the provided OpenStates latest-action data.

Where the Bill Stands

The provided source says the OpenStates refetch failed, so the bill's current position in the process could not be confirmed.
— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.
Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws